Frisch A, Marino L, Alsaadi D, Kasarabada A, Hua G, Ajebo G, et al. Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy. J Med Cases [Internet]. 2026 Jan. 1 [cited 2026 Jan. 10];17(1):28-31. Available from: https://jmc.elmerpub.com/index.php/jmc/article/view/5211